GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grape King Bio Ltd (TPE:1707) » Definitions » EBITDA Margin %

Grape King Bio (TPE:1707) EBITDA Margin % : 30.32% (As of Dec. 2024)


View and export this data going back to 1982. Start your Free Trial

What is Grape King Bio EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Grape King Bio's EBITDA for the three months ended in Dec. 2024 was NT$956 Mil. Grape King Bio's Revenue for the three months ended in Dec. 2024 was NT$3,155 Mil. Therefore, Grape King Bio's EBITDA margin for the quarter that ended in Dec. 2024 was 30.32%.


Grape King Bio EBITDA Margin % Historical Data

The historical data trend for Grape King Bio's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grape King Bio EBITDA Margin % Chart

Grape King Bio Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.62 29.05 30.22 29.36 28.58

Grape King Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.65 25.87 25.97 31.38 30.32

Competitive Comparison of Grape King Bio's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Grape King Bio's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grape King Bio's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grape King Bio's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Grape King Bio's EBITDA Margin % falls into.


;
;

Grape King Bio EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Grape King Bio's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=3189.825/11160.005
=28.58 %

Grape King Bio's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=956.457/3154.981
=30.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grape King Bio  (TPE:1707) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Grape King Bio EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Grape King Bio's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Grape King Bio Business Description

Traded in Other Exchanges
N/A
Address
No. 402, Jinling Road, Section 2, Pingzhen District, Taoyuan, TWN, 324
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicine, liquid tonic, drink, and healthy food. The company has three segments: MLM (Multi-Level Marketing) is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.

Grape King Bio Headlines

No Headlines